Inclisiran in advanced chronic kidney disease (stage G4-G5 non-dialysis): sustained LDL-C reduction and favorable safety profile at 1-year follow-up in a real-world case series.

Front Med (Lausanne) · 2026 · PMC13333467 · PMID 42440710

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Albuminuria showed a decreasing trend during follow-up.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.